 |
|
| Blog results | Results 1 - 10 of about 16,181 for MYLAN PHARMACEUTICALS, INC.. (0.30 seconds) |
| Sorted by relevance Sort by date |
| 8 Feb 2010 by milord But today I want to discuss a lawsuit filed last month in the Circuit Court of Monongalia County, West Virginia by Mylan, Inc. and its subsidiary, Mylan Pharmaceuticals, Inc., against the Pittsburgh Post-Gazette, two of its reporters, ... Law Office De Milord - http://lawofficedemilord.typepad.com/blog/ |
| 16 Jan 2010 by clarke LEVALBUTEROL HYDROCHLORIDEinhalant [Mylan Pharmaceuticals Inc.] Submitted by clarke on Sat, 01/16/2010 - 18:20. Pharmaceuticals · World Wide · LEVALBUTEROL HYDROCHLORIDEinhalant [Mylan Pharmaceuticals Inc.] - Updated Date: Jan 15, ... HIV ATLAS - http://www.hivatlas.org/ |
| 8 Feb 2010 by Patent Docs Mylan Pharmaceuticals Inc. 1:10-cv-00085; filed February 3, 2010 in the District Court of Delaware. • Plaintiffs: Pfizer Inc.; Pfizer Pharmaceuticals LLC; Pfizer Ireland Pharmaceuticals; Pfizer Ltd.; CP Pharmaceuticals International CV ... Patent Docs - http://www.patentdocs.org/ [ More results from Patent Docs ] |
| 6 Feb 2010 by imcenvec Abstract: Many patients with ma jor depressive disorder (MDD) present with cobcurrent substance use disotders (SUDs), whi ch has beeb thought tto impair their respobse antidepressants. Clinicians often delay antidepressant treatment ... Treatments and Healthy Life - http://imcenvec.blogetery.com/ [ More results from Treatments and Healthy Life ] |
| 4 Feb 2010 by sururac Conclusion.[mdash]] The combination tablet of sumatriptan/naproxen sodium haa unique pharmacokinetic properties. The rapid ansorption or sumatriptan with the delayed-release properties of naproxen sodium from sumatriptan/naproxen sodium ... Health and Top Medicines - http://sururac.iktib.com/ |
| 3 Feb 2010 Date Filed: Wednesday, February 03, 2010 @ Delaware District Court. RFC Express - Intellectual Property Lawsuits... - http://www.rfcexpress.com/ [ More results from RFC Express - Intellectual Property Lawsuits... ] |
| 29 Jan 2010 by Mary Davila Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and ... BioMedReports.Com - http://biomedreports.com/ |
| 29 Jan 2010 by Mylan 29 (HSMN NewsFeed) -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ... HSMN NewsFeed - http://salesandmarketingnetwork.com/?q=Save+Us+From+Berlusconi [ More results from HSMN NewsFeed ] |
| 29 Jan 2010 by Jack PITTSBURGH -- Mylan Inc. has announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 ... WVBusiness - http://wvbusiness.blogspot.com/ |
| 14 May 2008 Mylan Inc. today announced that Mylan Pharmaceuticals Inc. has launched Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, the generic version of Gla. Drugs.com - Pharma News - http://www.drugs.com/news.html [ More results from Drugs.com - Pharma News ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
